StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
SunTrust Said Need to See Gilead Sciences (GILD) Controlled Data on Remdesivir
April 23, 2020 1:32 PM
SunTrust analyst Robyn Karnauskas weighed in on Gilead Sciences (NASDAQ: GILD) related to news that a China trial of severe ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst Comments
Next Articles
WHO China Data Likely to Drive View that Gilead (GILD) Remdesivir Isn't Working in Severe Patients - Raymond James
April 23, 2020 2:00 PM
Gilead Sciences (GILD) China Trial Results 'In Line with our Expectations' - RBC
April 23, 2020 1:40 PM
Gilead Sciences (GILD) Remdesivir China Results 'Very Sobering' - Baird
April 23, 2020 1:34 PM
